EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The ketogenic diet alters microbiome‐metabolome profiles to improve West syndrome therapy

Gan Xie iD, Qian Zhou iD, Jianxiang Liao, Yuejie Zheng, Wenjian Wang, Kunling Shen iD

Pediatric Investigation · 2026-02 · 10 (1) · 10-24

DOI: 10.1002/ped4.70027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Investigation, online erschienen am 19.11.2025. Verfasst von Gan Xie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine Beijing Children's Hospital Capital Medical University National Center for Children's Health Beijing China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The ketogenic diet (KD) is effective in managing epilepsy, particularly West syndrome (WS); however, the role of gut microbiome (GM) and metabolome in its efficacy remains unclear. Understanding these mechanisms could optimize the KD for WS treatment.

Objective

To identify microbiome‐metabolome signatures associated with KD efficacy in WS by analyzing changes in GM composition and metabolic pathways.

Methods

Fecal samples were collected from WS patients ( n = 16) and healthy children ( n = 24). Metagenome and metabolome analyses were performed to assess GM composition and metabolic profiles.

Results

WS patients showed GM imbalances compared to healthy children. Disease status contributed sufficiently to the GM. The abundance of Bacteroides , Parabacteroides , and Faecalibacterium was lower in WS (3.30% vs. 39.86%, P ‐adj = 0.140; 0.14% vs. 0.73%, P ‐adj = 0.023; 0.04% vs. 1.35%, P ‐adj = 0.018), whereas Bifidobacterium and Escherichia were higher (6.08% vs. 2.23%, P ‐adj = 0.140; 7.57% vs. 0.15%, P ‐adj < 0.001). After KD, Parabacteroides (particularly P. distasonis ) and Bacteroides (particularly B. fragilis ) increased (0.14% vs. 0.35%, P ‐adj = 0.034; 3.30% vs. 21.18%, P ‐adj = 0.380); Bifidobacterium (particularly B. breve ) and Escherichia (particularly E. coli ) decreased from 6.08% and 7.57% to 1.24% and 2.52%, respectively. Kyoto Encyclopedia of Genes and Genomes pathway analysis demonstrated that ATP‐binding cassette (ABC) transporters, fatty acid biosynthesis, tyrosine metabolism, and other pathways were significantly altered in patients with WS, and these alterations were reversed following ketogenic diet (KD) consumption. The KD also altered intestinal metabolites. Integrative analysis of microbial features, gene functions, and metabolites revealed that Bacteroides species and P. distasonis were significantly associated with ABC transporters, alanine aspartate and glutamate metabolism, and negatively correlated with 3‐sulfinoalanine, suggesting potential regulatory roles in metabolic pathways.

Interpretation

KD induces significant shifts in GM composition and metabolic pathways, which may contribute to its therapeutic efficacy in WS. The restoration of Bacteroides and Parabacteroides dominance, alongside alterations in gene functions and neurotransmitter‐related metabolites, suggests a potential mechanism for the antiepileptic effects of KD.

Schlagwörter

Stichwörter der Autor:innen

EpilepsyGastrointestinal microbiotaKetogenic dietMetabolomics

Autor:innen und Institutionen

  • Department of Respiratory Medicine Beijing Children's Hospital Capital Medical University National Center for Children's Health Beijing China.
  • Department of Computer Science City University of Hong Kong Hong Kong China.
  • Department of Neurology Shenzhen Children's Hospital Shenzhen China.
  • Department of Respiratory Medicine Shenzhen Children's Hospital Shenzhen China.

ORCID-Profile: Gan Xie, Qian Zhou, Kunling Shen

Zitieren

APA

Xie, G., Zhou, Q., Liao, J., Zheng, Y., Wang, W., & Shen, K. (2026). The ketogenic diet alters microbiome‐metabolome profiles to improve West syndrome therapy. Pediatric Investigation, 10(1), 10-24. https://doi.org/10.1002/ped4.70027

Vancouver

Xie G, Zhou Q, Liao J, Zheng Y, Wang W, Shen K. The ketogenic diet alters microbiome‐metabolome profiles to improve West syndrome therapy. Pediatric Investigation. 2026;10(1):10-24. doi:10.1002/ped4.70027

BibTeX
@article{Xie2026,
  author = {Xie, Gan and Zhou, Qian and Liao, Jianxiang and Zheng, Yuejie and Wang, Wenjian and Shen, Kunling},
  title = {The ketogenic diet alters microbiome‐metabolome profiles to improve West syndrome therapy},
  journal = {Pediatric Investigation},
  year = {2026},
  volume = {10},
  number = {1},
  pages = {10--24},
  doi = {10.1002/ped4.70027}
}
Kostenlos starten →